基于膜的下游净化工艺的评估,作为单克隆抗体净化传统树脂珠的替代品

Victor Pasquier1, Kevin Botelho Ferreira1, Morgane Lergenmuller1

  • 1Biotech Development Center, Merck Serono SA (an affiliate of Merck KGaA, Darmstadt, Germany), Fenil-sur-Corsier, Switzerland.

Biotechnology progress
|September 16, 2024
PubMed
概括

膜色谱为净化单克隆抗体和Fc融合蛋白提供了一个高效的替代方案. 这些膜在许多周期中表现出强大的性能,有可能取代传统的树脂染色学.